Study Details
Full Title
A Phase 1, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants with Late-Onset Pompe Disease
Principal Investigator
Priya
Kishnani
Protocol Number
PRO00119896
NCT ID
NCT07354724
Phase
I
Enrollment Status
Open to Enrollment